Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection

NCT01482767 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

262

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Hepatitis C

Interventions

DRUG: Pegylated-Interferon Alfa 2b (PEG-IFN)
DRUG: Ribavirin (RBV)
DRUG: Boceprevir (BOC)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)